161 related articles for article (PubMed ID: 37460192)
1. Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
Martinsson A; Törngren C; Nielsen SJ; Pan E; Hansson EC; Taha A; Jeppsson A
Heart; 2024 Jan; 110(3):202-208. PubMed ID: 37460192
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study.
Goel SS; Aksoy O; Gupta S; Houghtaling PL; Tuzcu EM; Marwick T; Mihaljevic T; Svensson L; Blackstone EH; Griffin BP; Stewart WJ; Barzilai B; Menon V; Kapadia SR
Ann Intern Med; 2014 Nov; 161(10):699-710. PubMed ID: 25402513
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation.
Ochiai T; Saito S; Yamanaka F; Shishido K; Tanaka Y; Yamabe T; Shirai S; Tada N; Araki M; Naganuma T; Watanabe Y; Yamamoto M; Hayashida K
Heart; 2018 Apr; 104(8):644-651. PubMed ID: 28986405
[TBL] [Abstract][Full Text] [Related]
4. Medical therapy after surgical aortic valve replacement for aortic regurgitation.
Törngren C; Jonsson K; Hansson EC; Taha A; Jeppsson A; Martinsson A
Eur J Cardiothorac Surg; 2023 May; 63(5):. PubMed ID: 36748999
[TBL] [Abstract][Full Text] [Related]
5. Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
Chen S; Redfors B; Nazif T; Kirtane A; Crowley A; Ben-Yehuda O; Kapadia S; Finn MT; Goel S; Lindman BR; Alu MC; Chau KH; Thourani VH; Vahl TP; Douglas PS; Kodali SK; Leon MB
Eur Heart J; 2020 Feb; 41(8):943-954. PubMed ID: 31711153
[TBL] [Abstract][Full Text] [Related]
6. Relation Between Renin-Angiotensin System Blockers and Survival Following Isolated Aortic Valve Replacement for Aortic Stenosis.
Magne J; Guinot B; Le Guyader A; Bégot E; Marsaud JP; Mohty D; Aboyans V
Am J Cardiol; 2018 Feb; 121(4):455-460. PubMed ID: 29254679
[TBL] [Abstract][Full Text] [Related]
7. Associations between medical therapy after surgical aortic valve replacement for aortic stenosis and long-term mortality: a report from the SWEDEHEART registry.
Baranowska J; Törngren C; Nielsen SJ; Lindgren M; Björklund E; Ravn-Fischer A; Skoglund K; Jeppsson A; Martinsson A
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):837-846. PubMed ID: 35583235
[TBL] [Abstract][Full Text] [Related]
8. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
[TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.
Rodriguez-Gabella T; Catalá P; Muñoz-García AJ; Nombela-Franco L; Del Valle R; Gutiérrez E; Regueiro A; Jimenez-Diaz VA; Ribeiro HB; Rivero F; Fernandez-Diaz JA; Pibarot P; Alonso-Briales JH; Tirado-Conte G; Moris C; Diez Del Hoyo F; Jiménez-Britez G; Zaderenko N; Alfonso F; Gómez I; Carrasco-Moraleja M; Rodés-Cabau J; San Román Calvar JA; Amat-Santos IJ
J Am Coll Cardiol; 2019 Aug; 74(5):631-641. PubMed ID: 31370954
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
11. Midterm Outcomes Following Sutureless and Transcatheter Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
Vilalta V; Alperi A; Cediel G; Mohammadi S; Fernández-Nofrerias E; Kalvrouziotis D; Delarochellière R; Paradis JM; González-Lopera M; Fadeuilhe E; Carrillo X; Abdul-Jawad Altisent O; Rodríguez-Leor O; Voisine P; Bayés-Genís A; Rodés-Cabau J
Circ Cardiovasc Interv; 2021 Nov; 14(11):e011120. PubMed ID: 34607449
[TBL] [Abstract][Full Text] [Related]
12. Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population.
Barbanti M; Tamburino C; D'Errigo P; Biancari F; Ranucci M; Rosato S; Santoro G; Fusco D; Seccareccia F;
Circ Cardiovasc Interv; 2019 Jul; 12(7):e007825. PubMed ID: 31284737
[TBL] [Abstract][Full Text] [Related]
13. Acute Kidney Injury and Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.
Phuong N; Solomon RJ; DeSarno MJ; LeWinter MM; Zimmer J; Dauerman HL
J Invasive Cardiol; 2021 Aug; 33(8):E662-E669. PubMed ID: 34338656
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: An updated meta-analysis.
Goel S; Pasam RT; Wats K; Patel J; Chava S; Gotesman J; Malik BA; Frankel R; Shani J; Gidwani U
Catheter Cardiovasc Interv; 2020 Jul; 96(1):169-178. PubMed ID: 31631514
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves.
Côté N; Couture C; Pibarot P; Després JP; Mathieu P
Eur J Clin Invest; 2011 Nov; 41(11):1172-9. PubMed ID: 21988540
[TBL] [Abstract][Full Text] [Related]
16. Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
Sun Y; Li J; Li G; Fan R; Luo J
Catheter Cardiovasc Interv; 2021 Jan; 97(1):E88-E94. PubMed ID: 32311209
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury as the most important predictor of poor prognosis after interventional treatment for aortic stenosis.
Korczak A; Morawiec R; Stegienta M; Ryk A; Walczak A; Krekora J; Krejca M; Drożdż J
Kardiol Pol; 2022; 80(10):1032-1038. PubMed ID: 35924995
[TBL] [Abstract][Full Text] [Related]
18. Major adverse cardiac events and functional capacity in patients at intermediate risk undergoing transcatheter versus surgical aortic valve replacement for aortic stenosis with bicuspid valves.
Tsai HY; Lin YS; Wu IC; Kuo LY; Chen BY; Shen SL; Hsu WN; Huang HY
J Card Surg; 2021 Mar; 36(3):828-833. PubMed ID: 33428212
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.
Siontis GCM; Overtchouk P; Cahill TJ; Modine T; Prendergast B; Praz F; Pilgrim T; Petrinic T; Nikolakopoulou A; Salanti G; Søndergaard L; Verma S; Jüni P; Windecker S
Eur Heart J; 2019 Oct; 40(38):3143-3153. PubMed ID: 31329852
[TBL] [Abstract][Full Text] [Related]
20. Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.
Fischer-Rasokat U; Bänsch C; Renker M; Rolf A; Charitos EI; Weferling M; Liebetrau C; Herrmann E; Choi YH; Hamm CW; Kim WK
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):815-824. PubMed ID: 35441662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
